Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
SB 431542, Tocris Bioscience™
Potent, selective inhibitor of TGF-βRI, ALK4 and ALK7
Supplier: R&D Systems 1614/1
This item is not returnable.
View return policy
Description
SB 431542 is a potent and selective inhibitor of the transforming growth factor-β (TGF-β) type I receptor/ALK5 (IC50 = 94 nM), and its relatives ALK4 and ALK7. Suppresses TGF-β-induced proliferation of human osteosarcoma cells. Replaces SOX2 in reprogramming of fibroblasts into iPSCs. Stimulates proliferation, differentiation and sheet formation of ESC-derived endothelial cells. Inhibits TGF-β-induced EMT, migration, invasion and VEGF secretion in several human cancer cell lines.
SB 431542 synthesized to cGMP guidelines also available.
For more information about how SB 431542 may be used, see our protocols: 3D Culture of Lung Alveolar Cells, Differentiation of Hematopoietic Progenitors from hPSCs, Generating Midbrain Dopaminergic Neurons from hPSCs, Generating Vascular Organoids, Accelerated Induction of Cortical Neurons from hiPSCs .
Specifications
| SB431542 | |
| 4-5-benzo 1,3 dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl-benzamide | |
| C22H16N4O3 |
| 301836-41-9 | |
| 1 mg | |
| 384.39 |
Safety and Handling
Recommended Storage : Store at Room Temperature
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction